A Comparative Study between Oxcarbazepine and Gabapentin Regarding Therapeutic Efficiency and Tolerability in the Treatment of Trigeminal Neuralgia

Trigerninal neuralgia is a relapsing and remittent disorder is best symptomatically treated by medical treatment out of which carbamazepine thought to be a diagnostic drug marker of trigeminal neuralgia, has often undesirable side effects and sometimes ineffective, limiting its usage, thus search fo...

Full description

Bibliographic Details
Main Authors: Fakir Mohan Debta, Anil G Ghom, Jigna S Shah, Priyanka Debta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2010-01-01
Series:Journal of Indian Academy of Oral Medicine and Radiology
Subjects:
Online Access:http://www.jiaomr.in/article.asp?issn=0972-1363;year=2010;volume=22;issue=1;spage=10;epage=17;aulast=Debta;type=0
_version_ 1818527461576540160
author Fakir Mohan Debta
Anil G Ghom
Jigna S Shah
Priyanka Debta
author_facet Fakir Mohan Debta
Anil G Ghom
Jigna S Shah
Priyanka Debta
author_sort Fakir Mohan Debta
collection DOAJ
description Trigerninal neuralgia is a relapsing and remittent disorder is best symptomatically treated by medical treatment out of which carbamazepine thought to be a diagnostic drug marker of trigeminal neuralgia, has often undesirable side effects and sometimes ineffective, limiting its usage, thus search for more effective drug with lesser side effect is still on. Recently two newer anticonvulsant oxcarbazepine (OXC) a ketoderivative of carbamazepine and gabapentin (GBP) has been trailed in trigeminal neuralgia in different open clinical trial as monotherapy with encouraging results. These drugs have convenient dosage and surprisingly fewer side effects. These facts that trigeminal neuralgia responds to newer anticonvulsant (oxcarbazepine, gabapentin) in a better perspective, enabled me to conduct the present clinical trial on 54 patients (both in newly diagnosed TN patient and refractive patient) of trigeminal neuralgia who were made two randomized group for separate monotherapy study for a period of six months. The therapeutic effect of OXC and gabapentin (GBP) in relation to reduction in number of attacks of pain and severity of pain were evaluated. All the scoring data showed OXC is more therapeutic efficacious cost-effective and well-tolerated profile than gabapentin and an emerging as a drug for treatment of TN in both new and refractive patients.
first_indexed 2024-12-11T06:36:24Z
format Article
id doaj.art-f52e840f5ab646f3abb83186dae0f854
institution Directory Open Access Journal
issn 0972-1363
0975-1572
language English
last_indexed 2024-12-11T06:36:24Z
publishDate 2010-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Indian Academy of Oral Medicine and Radiology
spelling doaj.art-f52e840f5ab646f3abb83186dae0f8542022-12-22T01:17:22ZengWolters Kluwer Medknow PublicationsJournal of Indian Academy of Oral Medicine and Radiology0972-13630975-15722010-01-012211017A Comparative Study between Oxcarbazepine and Gabapentin Regarding Therapeutic Efficiency and Tolerability in the Treatment of Trigeminal NeuralgiaFakir Mohan DebtaAnil G GhomJigna S ShahPriyanka DebtaTrigerninal neuralgia is a relapsing and remittent disorder is best symptomatically treated by medical treatment out of which carbamazepine thought to be a diagnostic drug marker of trigeminal neuralgia, has often undesirable side effects and sometimes ineffective, limiting its usage, thus search for more effective drug with lesser side effect is still on. Recently two newer anticonvulsant oxcarbazepine (OXC) a ketoderivative of carbamazepine and gabapentin (GBP) has been trailed in trigeminal neuralgia in different open clinical trial as monotherapy with encouraging results. These drugs have convenient dosage and surprisingly fewer side effects. These facts that trigeminal neuralgia responds to newer anticonvulsant (oxcarbazepine, gabapentin) in a better perspective, enabled me to conduct the present clinical trial on 54 patients (both in newly diagnosed TN patient and refractive patient) of trigeminal neuralgia who were made two randomized group for separate monotherapy study for a period of six months. The therapeutic effect of OXC and gabapentin (GBP) in relation to reduction in number of attacks of pain and severity of pain were evaluated. All the scoring data showed OXC is more therapeutic efficacious cost-effective and well-tolerated profile than gabapentin and an emerging as a drug for treatment of TN in both new and refractive patients.http://www.jiaomr.in/article.asp?issn=0972-1363;year=2010;volume=22;issue=1;spage=10;epage=17;aulast=Debta;type=0TNfacial painOxcarbazepinegabapentin
spellingShingle Fakir Mohan Debta
Anil G Ghom
Jigna S Shah
Priyanka Debta
A Comparative Study between Oxcarbazepine and Gabapentin Regarding Therapeutic Efficiency and Tolerability in the Treatment of Trigeminal Neuralgia
Journal of Indian Academy of Oral Medicine and Radiology
TN
facial pain
Oxcarbazepine
gabapentin
title A Comparative Study between Oxcarbazepine and Gabapentin Regarding Therapeutic Efficiency and Tolerability in the Treatment of Trigeminal Neuralgia
title_full A Comparative Study between Oxcarbazepine and Gabapentin Regarding Therapeutic Efficiency and Tolerability in the Treatment of Trigeminal Neuralgia
title_fullStr A Comparative Study between Oxcarbazepine and Gabapentin Regarding Therapeutic Efficiency and Tolerability in the Treatment of Trigeminal Neuralgia
title_full_unstemmed A Comparative Study between Oxcarbazepine and Gabapentin Regarding Therapeutic Efficiency and Tolerability in the Treatment of Trigeminal Neuralgia
title_short A Comparative Study between Oxcarbazepine and Gabapentin Regarding Therapeutic Efficiency and Tolerability in the Treatment of Trigeminal Neuralgia
title_sort comparative study between oxcarbazepine and gabapentin regarding therapeutic efficiency and tolerability in the treatment of trigeminal neuralgia
topic TN
facial pain
Oxcarbazepine
gabapentin
url http://www.jiaomr.in/article.asp?issn=0972-1363;year=2010;volume=22;issue=1;spage=10;epage=17;aulast=Debta;type=0
work_keys_str_mv AT fakirmohandebta acomparativestudybetweenoxcarbazepineandgabapentinregardingtherapeuticefficiencyandtolerabilityinthetreatmentoftrigeminalneuralgia
AT anilgghom acomparativestudybetweenoxcarbazepineandgabapentinregardingtherapeuticefficiencyandtolerabilityinthetreatmentoftrigeminalneuralgia
AT jignasshah acomparativestudybetweenoxcarbazepineandgabapentinregardingtherapeuticefficiencyandtolerabilityinthetreatmentoftrigeminalneuralgia
AT priyankadebta acomparativestudybetweenoxcarbazepineandgabapentinregardingtherapeuticefficiencyandtolerabilityinthetreatmentoftrigeminalneuralgia
AT fakirmohandebta comparativestudybetweenoxcarbazepineandgabapentinregardingtherapeuticefficiencyandtolerabilityinthetreatmentoftrigeminalneuralgia
AT anilgghom comparativestudybetweenoxcarbazepineandgabapentinregardingtherapeuticefficiencyandtolerabilityinthetreatmentoftrigeminalneuralgia
AT jignasshah comparativestudybetweenoxcarbazepineandgabapentinregardingtherapeuticefficiencyandtolerabilityinthetreatmentoftrigeminalneuralgia
AT priyankadebta comparativestudybetweenoxcarbazepineandgabapentinregardingtherapeuticefficiencyandtolerabilityinthetreatmentoftrigeminalneuralgia